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Background: Venous and arterial thrombotic diseases are 
serious health concerns with well established links to the Factor V 
Leiden (G1691A), Prothrombin (G20210A), MTHFR (C677T) and 
MTHFR (A1298C) mutations. The likelihood of developing 
disease is increased with the presence of mutations in multiple 
clotting factor genes.
  
Methods: Four amplicons with non-overlapping melting 
temperature windows were created by varying the amplicon 
lengths from 40 base pairs to 120 base pairs and by using primers 
with G/C rich tails. Genotyping of each locus in the same 
closed-tube was based on the shape and position of the 
high-resolution melting transition. Heteroduplex melting analysis 
with LCGreen eliminated any need for probes.
Results: The Tm windows for each gene were separated by at 
least 1°C with the wild type melting temperatures of 76.0°C for 
Factor V Leiden, 88.5°C for Prothrombin, 84.5°C for MTHFR 
C677, and 80.5°C for MTHFR A1298. Within each window, the 
wild type, mutant, and heterozygous genotypes for each mutation, 
were resolvable. Concordant results between conventional 
LightCycler analysis and high-resolution melting were obtained on 
120 blinded clinical samples.
Conclusions: Genotyping by amplicon melting is a rapid, 
closed-tube method for genotyping without probes that can be 
multiplexed. The method was successfully applied to the four 
most common clotting factor mutations in a single tube. The 
simplicity of the method allows rapid development of low-cost 
assays and does not require any arrays or complex 
instrumentation.
Venous and arterial thrombotic disease are serious health 
concerns throughout the world.  Venous thrombosis is a 
multifactorial disease caused by the interaction of lifestyle and 
genetic factors. Genetic factors include well established links 
between the Factor V Leiden (G1691A) and Prothrombin 
(G20210A) mutations and increased risk of thromboembolic 
disease and coronary artery disease. Two other mutations have 
been linked to coronary artery and venous thrombosis disease 
through their effect on homocysteine metabolism. The mutations 
occur in the methylenetetrahydrofolate reductase (MTHFR) gene.  
The two observed mutations are (C677T) and (A1298C) which 
both cause hyperhomocysteinaemia.
Analytical DNA assays for the identification of these clotting 
factor mutations are broadly used in the clinical laboratory.  
Commercial and home-brew assays for these mutations are most 
commonly tested for by Fluorescence Resonance Energy 
Transfer (FRET) hybridization probes which are expensive.
As demand grows for these assays, so does the need for 
rapid, reliable, and cost effective methods of detection. 
Samples: 120 clinical Factor V Leiden, Prothrombin, MTHFR 677 
and 1298 whole blood samples were collected in K3EDTA, 
Na-Heparin, and CPD tubes and stored at 4°C. Samples were 
deidentified according to HIPPA regulations.
Nucleic Acid Extraction: MagNA Pure LC DNA Isolation Kit I 
(Roche)
Nucleic Acid Amplification: 
 LightCycler (Roche)
 LightCycler FastStart DNA Master HybProbe Kit (Roche)
  20 µL reaction
   1X Kit master mix
   3.5 mM MgCl2 
   0.1 to 0.5 µM of each primer
   1X LightCycler Green Plus (Idaho Technologies)
   1 U heat-labile UNG (Roche)
   4 µL of DNA.  
  Cycling Parameters
   95°C 15 minute enzyme activation
   Amplification (45 cycles ~ 25 minutes)
    2 second denaturation at 95°C
    1 second anneal at 56°C
    1 second elongation/fluorescence acquisition at 72°C.
Standard Testing of Clinical Samples:
Prothrombin genotypes were verified by the Factor II 
(Prothrombin) G20210A Kit (Roche)
Factor V Leiden genotypes were verified by the Factor V Leiden 
Kit (Roche)
MTHFR 677 and 1298 genotypes were verified by the ARUP 
assay
High Resolution Melting Analysis: HR-1 (Idaho Technology)
MULTIPLEX PCR DESIGN
Amplicon Design: The quadriplex amplicons were designed to fit in distinct melting temperature windows. This was accomplished by adjusting the length and 
G/C content of the amplicon and use of tailing primers.
Melting Curve Resolution: PCR’s within the quadriplex have different amplification efficiencies and the specific amplicons fluoresce differently. Primer 
concentrations were varied to optimize resolution and to adjust fluorescence signal strength for each temperature window.
HIGH RESOLUTION MELTING ANALYSIS
 Melting curves were generated using the HR-1 instrument (Idaho Technology) with a temperature transition rate of 0.1°C/s.  
 A Super Heterozygous sample (Factor V Het, MTHFR 1298 and 677 Het, and Prothrombin Mut) was used as a control for Tm alignment.
The Factor V Leiden and Prothrombin quadriplex genotype results 
showed a 95% correlation. The MTHFR 1298 and 677 quadriplex 
genotype results showed a 96% and 97% correlation, respectively. 
The overall genotype correlation for the quadriplex was 96% for 
wildtype, 93% for mutants, and 95% for heterozygous samples.
The majority of the incorrectly genotyped Factor V, MTHFR 1298 and 
677, and Prothrombin samples were the result of peak Tm shifts 
which were observed in each Tm window of the quadriplex.  It is 
suspected that salt concentration variations due to extraction effects 
and/or reation efficiencies cause the Tm windows to shift left or right.  
The five discordant MTHFR 1298 samples were called heterozygous 
by the quadriplex assay and wild type by the ARUP assay. This was 
most likely due to a mutation outside of the FRET probe region of the 
ARUP assay which was picked up by the quadriplex assay. These 
samples will be sequenced to determine the presence of other 
mutations in the amplicon region.
RESULTS
Genotyping: Negative first derivative melting data for the blinded 
samples were compared to a super heterozygous control. 
Homozygous genotypes (wild type and mutant) were differentiated 
based on peak Tm while the heterozygous genotypes were 
differentiated based on derivative curve shape.
Using the most common clotting factor mutations as a model, the 
ease of genotyping by multiplexing PCR’s through the shifting of 
amplicon Tm’s has been demonstrated.
Single color fluorescent dye multiplex PCR is a rapid and less 
expensive alternative to current methods of genotyping because 
multiple genotypes can be differentiated in a single reaction and no 
expensive labeled probes are used.
This assay would benefit from the addition of a Tm reference control 



















































Wild Type Tm = 88.5°C
5'-GCAGATCCCTGGACAGG . G
CCTTATGTCCATAAAACAGG-5'.A
Wild Type Tm = 76°C







5'-GAAGCAGGGAGCTTTGAGGCTGACCTG ... (25bp) ...
CGACTGTGTAAGAAGGCGAAACACTTCCGT-5'... (25bp) ...
